BAA Edinburgh Airport 
Edinburgh Airport is dedicated to route development, and works closely with the City of Edinburgh Council and Visit Scotland to promote Edinburgh as a destination. 


BAA recognised that passengers prefer to fly direct from Scotland and in 2002 BAA Scotland introduced a £60 million Route Development Fund in a bid to increase the number of international flights available from Scotland. In 2006, the fund was increased to £95 million. 

A report by the Fraser of Allander Institute showed that under BAA's leadership and management, Edinburgh Airport contributes over £290 million a year to the Scottish economy and supports more than 7,500 jobs across Scotland, including 2,300 directly employed at the airport. 
Over the past 10 years more than £220 million has been spent upgrading terminal and airfield facilities at Edinburgh, to cater for the forecast increase in passenger numbers, including the award-winning £11 million Air Traffic Control Tower and the redevelopment of the forecourt. 
With passenger numbers set to double within a decade, BAA Edinburgh has earmarked almost £300 million for investment in new infrastructure over the next 10 years. 
The Edinburgh Airport Master Plan, which looks forward to how the airport might develop between now and 2030, was formally launched in July 2006 by managing director Richard Jeffrey. 
More than 40 airlines fly to over 80 destinations from Edinburgh Airport 
The 25-year blueprint includes: 
 Thousands of new jobs for local people 
 Improved benefits for Scotland's economy and tourism industry 
 26 million passengers a year by 2030 
 More international visitors travelling direct than ever before 
 Multi-million pound BAA investment programme 
 All developments underpinned by environmental strategies, including key commitments on increased public transport. 




Little France Medical & Life Sciences Campus 
(part of the South East Edinburgh development) 
This development is part of the Edinburgh Science Triangle and will create a world-class Centre for Biomedical Research in 100 acres of commercial space. The location of this development is particularly important as the site is adjacent to the new Royal Infirmary of Edinburgh, the University of Edinburgh's medical school and the Queens Medical Research Institute. The goal of the development is to create linkages between academic, clinical and commercial elements at Little France and develop further opportunities for translational medicine in Edinburgh. 
Work began in June 2005 with a completion date of 2020. The new site will also be the new home for The Roslin Cells Centre (RCC), a partnership between the Roslin Institute, Scottish Enterprise Edinburgh and Lothian, the University of Edinburgh and Scottish National Blood Transfusion Service (SNBTS). The centre will create clinically useable human stem cell lines compliant with UK and European regulatory requirements. The RCC is currently located at the Roslin Institute. At its new location, it will be next to the University of Edinburgh's Centre for Regenerative Medicine to create a hub for scientists, researchers and international companies working in this field of expertise.